Dear Healthcare Professional Letter Janssen Jan[removed]

First Page		Document Content
Pharmacology Pharmaceutical sciences Enantiopure drugs Pyrrolidines Doripenem Imipenem Ventilator-associated pneumonia MedWatch Adverse Event Reporting System Carbapenem antibiotics Food and Drug Administration Medicine		Dear Healthcare Professional Letter Janssen Jan[removed] Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 347,59 KB Share Document on Facebook

	Performance of the new Accelerate ID/AST System in highly resistant Acinetobacter baumannii bloodstream infection isolates, compared to routine laboratory testing Lisby G1, Kyst S1, Knudsen JD1, Turng B2, Metzger S2, Lit DocID: 1psgc - View Document
	The Treatment of Resistant Bacterial Infection in Children Andrew Whitelaw Division of Medical Microbiology, University of Stellenbosch & NHLS South African Antibiotic Stewardship DocID: 18vJS - View Document
	Antimicrobial Resistant Phenotype Definitions February 2015 NHSN Analysis Output Options for HAI data Phenotype Name DocID: Y2Z3 - View Document
	Articles Chlorine Dioxide Gas Inactivation of Beta-Lactams Kevin Lorcheim ClorDiSys Solutions, Inc., Lebanon, New Jersey DocID: PmjN - View Document
	Rationale for the EUCAST clinical breakpoints DocID: OftI - View Document